A 62-year-old man with a medical history of aortic valve replacement was referred to our hospital with high-grade fever. Blood culture was positive for Streptococcus dysgalactiae, and the echocardiogram showed edematous aortic annulus, suggesting a perivalvular abscess. Treatment with antibiotics was started, which showed progressive improvement. The echocardiogram at 2 weeks after admission showed progression of the perivalvular abscess, resulting in the formation of a perivalvular pseudoaneruysm, which revealed rapid enlargement. The patient underwent surgical resection of a 20-mm pseudoaneurysm, originating from the right and left coronary cusp. Complete resection of the infective tissue was performed, and an aortic root replacement was done. This case highlights that a frequent followup should be performed in case of perivalvular abscess, because of the risk of pseudoaneurysm formation, which may cause a life-threatening outcome.
Introduction
Endocarditis is an infection usually localized to the valve leaflets. However, invasive bacteria such as Staphylococcus aureus is known to invade the valve annulus, forming a perivalvular abscess. 1) Anguera et al. reported that aortocavitary fistula formation was detected in 1.6% of infective endocarditis cases.
2) Furthermore, these abscesses are much more common and more extensive in the presence of prosthetic valve endocarditis.
3) Here, we report a case of rapidly enlarging pseudoaneurysm emerging from perivalvular abscess caused by Streptococcus dysgalactiae in the presence of prosthetic valve.
The patient was successfully treated by debridement of the infected tissues and aortic root replacement.
Case Report
A 62 year old male who had aortic valve replacement with a carpentier edwards pericardial zenograft (Edwards Lifesciences, Irvine, California, USA) 4 years previously was referred to our hospital with high-grade fever. Blood culture was positive for Streptococcus dysgalactiae, and echocardiography was performed for suspected infective endocarditis. Echocardiogram showed edematous aortic annulus, but neither vegetation, nor perivalvular leakage was observed (Fig. 1A and 1B) . He was treated with penicillin, gentamicin and rifampicin under the diagnosis of infective endocarditis, which showed progressive improvement in laboratory data. Echocardiography was followed every one to two weeks. Edematous aortic annulus was enlarged, and at two weeks, perivalvular, echo-free space was confirmed ( Fig. 1C and 1D) . Color doppler revealed blood flow into the echo-free space revealing perivalvular pseudoaneurysm. In 6 weeks, the echo-free space was enlarged to 20 mm ( Fig. 1E and 1F) , which was also confirmed by multi detector-row computed tomography ( Fig. 2A) . The patient underwent surgical treatment.
Because of the prior history of median sternotomy, the right axillary artery, the right femoral artery and the right femoral vein was first secured for possible need of emergent cardiopulmonary bypass (CPB). Thoracotomy was carefully performed through a median sternotomy. Adhesion was carefully removed, and CPB was established with the right axillary artery, superior vena cava and right atrium-inferior vena cava. Venting of the left ventricle was performed through the left atrium-left ventricle, and the ascending aorta was clamped. The aortic root cardioplegia was administered anterograde followed by retrograde cardioplegia for obtaining cardiac arrest. The aortic root was carefully observed through an aortotomy. Although the previous prosthetic valve was preserved in shape and function, the annulus, at the right and left coronary cusps, was fragile, forming a pseudoaneurysm of the sinus of valsalva (Fig. 3A) . The coronary cusps of the left and right coronary arteries were also fragile and their mobility was also restricted due to adhesion. Debridement of the infected tissue was performed. Owing to the fragility of perivalvular tissue, we reconstructed the aortic root with a handmade aortic valve graft, constructed with a 23-mm mechanical valve (St. Jude Medical, Inc., St. Paul, Minnesota, USA) and 26 mm prosthetic graft (J-Graft; Japan Lifeline Co., Ltd. Shinagawa, Tokyo, JPN). The right coronary ostium was closed due to its fragility, and bypass grafting with the saphenous vein graft was performed. Because of restriction in mobility of the left coronary artery due to adhesion, the left coronary artery was reconstructed with a 9mm prosthetic graft with Piehler's technique (Fig. 3B) . Discontinuation of cardiopulmonary bypass was easy, and the patient was safely transferred to intensive care unit. For further antibiotics treatment, penicillin, gentamicin and rifampicin were continued for 4 weeks after the operation which was followed by oral administration of amoxicillin hydrate. The postoperative course was uneventful, and the patient was discharged from the hospital without any major complications. Post operative multi detector-row computed tomography showed complete exclusion of the pseudoaneurysm (Fig. 2B) . 
Discussion
Pseudoaneurysm of the sinus of valsalva is exceedingly rare. It may arise from any of the three sinuses of Valsalva, either congenitally, spontaneously, or after trauma or infection. 4) Bacteria such as Staphylococcus aureus is known for its tendency to invade the annulus forming a perivalvular abscess which may present highdegree fever, atrial ventricular block, aortic insufficiency, pericarditis, and persistent sepsis despite the use of antibiotics.
1)
Sutton et al. reported histological studies demonstrating the structural weakness between aortic wall and the annulus.
5) The infection invades this structural weakness forming aorto-cavitary fistula or pseudoaneurysm. Acquired aneurysm of the sinus of valsalva most often protrudes outside the cardiac chamber, while congenital aneurysm of sinus of valsalva usually protrudes and ruptures into the adjacent cardiac chamber. [6] [7] [8] [9] In either cases, rupture of the aneurysm may cause a life-threatening outcome. Progression of the pseudoaneurysm should be followed frequently for indication for surgery which is based on the risk of sudden rupture. 10) Thickening of the aortic annulus in the echocardiogram and positive blood culture for Streptococcus dysgalactiae suggested a perivalvular abscess in the presence of prosthetic valve. Infection by Streptococcus dysgalactiae caused an aggressive inflammatory invasion of the perivalvular tissue, resulting in a rapidly enlarging pseudoaneurysm, suggesting an impending rupture of the aneurysm. However, despite aggressive infection, the prosthetic valve was preserved in shape and function, which allowed an adequate administration of antibiotics before surgery, thus enabling systemic infection control.
The defect in the sinus of valsalva may be treated by direct closure, or patch plasty. A combination of approaches, through the chamber of termination and aortotomy, allows observation of the aortic root and aortic valve, simultaneously, thus preventing aortic valve twisting and aortic valve regurgitation. 11) However, in the case of infection, debridement should be performed for a total exclusion of infected tissue, which sometimes produces annular tissue damage.
12) Aortic root replacement may be preferred over patch plasty in these cases for complete removal of the infected tissue.
Treatment of perivalvular abscess is complicated due to its ability to progress through invading inflammation. The cause of the infection should be evaluated promptly, and appropriate antibiotics should be administered to prevent tissue destruction and formation of pseudoaneurysm. Once pseudoaneurysm is formed, infection should be controlled, and debridement of the perivalvular tissue should be performed with care for complete resection of the infection. Adequate treatment for infection and frequent follow-up with echocardiography should be performed in cases of perivalvular abscess, due to the risk of pseudoaneurysm formation, which may cause a lifethreatening outcome.
Conclusion
We presented a case of successful aortic root replacement for perivalvular psuedoaneurysm caused by Streptococcus dysgalactiae in the presence of prosthetic aortic valve endocarditis.
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